Detects inherited variants in the BRCA1 and BRCA2 genes associated with increased risks of breast, ovarian, prostate, pancreatic and certain other cancers.
Used to assess inherited cancer susceptibility in selected people with a relevant personal or family history and to help inform screening, prevention or treatment decisions.